Literature DB >> 11532387

Withdrawal-emergent rabbit syndrome during dose reduction of risperidone.

K Nishimura1, M Tsuka, N Horikawa.   

Abstract

Rabbit syndrome (RS) is a rare extrapyramidal side effect caused by prolonged neuroleptic medication. Here we present a case of withdrawal-emergent RS, which is the first of its kind to be reported. The patient developed RS during dose reduction of risperidone. The symptom was treated successfully with trihexyphenidyl anticholinergic therapy. The underlying mechanism of withdrawal-emergent RS in the present case may have been related to the pharmacological profile of risperidone, a serotonin-dopamine antagonist, suggesting the pathophysiologic influence of the serotonin system in the development of RS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11532387     DOI: 10.1016/s0924-977x(01)00095-5

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  4 in total

1.  Aripiprazole withdrawal: a case report.

Authors:  Randy A Sansone; Robert J Sawyer
Journal:  Innov Clin Neurosci       Date:  2013-05

Review 2.  Antipsychotic-induced rabbit syndrome: epidemiology, management and pathophysiology.

Authors:  Miguel Schwartz; Shraga Hocherman
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

3.  Clozapine-induced rabbit syndrome: a case report.

Authors:  Cicek Hocaoglu
Journal:  Ment Illn       Date:  2009-10-30

4.  Newer antipsychotics and the rabbit syndrome.

Authors:  Mario Catena Dell'osso; Andrea Fagiolini; Francesca Ducci; Azadeh Masalehdan; Antonio Ciapparelli; Ellen Frank
Journal:  Clin Pract Epidemiol Ment Health       Date:  2007-06-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.